Search
Golvatinib
go.drugbank.com/drugs/DB11977InvestigationalGolvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
Categories: Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitorsIntegrin alpha-2
go.drugbank.com/bio_entities/BE0012664TargetHumansIntegrin alpha-2/beta-1 is a receptor for laminin, collagen, collagen C-propeptides, fibronectin and E-cadherin. It recognizes the proline-hydroxylated sequence G-F-P-G-E-R in collagen.
Synonyms: Collagen receptorAetiocholanolone
go.drugbank.com/drugs/DB02854ExperimentalEtiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine. [PubChem]
Abdavomeran
go.drugbank.com/drugs/DB15695Investigational[L15012] The modRNA is formulated in lipid nanoparticles for delivery via intramuscular injection. … [L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein together with a "foldon" trimerization domain derived
Categories: Experimental Unapproved Treatments for COVID-19Morinamide
go.drugbank.com/drugs/DB13417InvestigationalCategories: Antiinfectives for Systemic Use, Drugs for Treatment of TuberculosisDarifenacin
go.drugbank.com/drugs/DB00496ApprovedInvestigationalIt is unknown if M3 receptor selectivity is clinically advantageous in overactive bladder syndrome treatments.
Categories: Drugs for Urinary Frequency and Incontinence, Cytochrome P-450 SubstratesCenderitide
go.drugbank.com/drugs/DB11777InvestigationalCenderitide is under investigation for the treatment of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.
SB 224289
go.drugbank.com/drugs/DB17052ExperimentalSB-224289 is a small molecule with a high affinity for human 5-HT1B receptors.[A253122]
rAAV9-rsATP7A
go.drugbank.com/drugs/DB17664ExperimentalA recombinant adeno-associated viral vector gene therapy under investigation for the treatment of Menkes disease.
PLG-0206
go.drugbank.com/drugs/DB18116InvestigationalPLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections.[L48106]